SGH Medical Pharma is aiming for turnover of €100 million, which will enable it to reach the critical mass sought by our laboratory customers and manage the structural costs associated with regulatory requirements. I attach critical importance to compliance with laws, regulations and universal ethical principles. Our corporate social responsibility policy reflects our commitment through the rules and ethical principles it supports and protects, and to which it is actively committed. Promoting this culture and demanding compliance is, in our view, essential: we must be able to guarantee that we always act with integrity.
We will therefore increase our turnover alongside, the organisation’s clear desire to incorporate social and environmental considerations into its decision-making but we will also well equipped to account for the impact of its decisions and activities on society and the environment.